Weekly Swing Watchlist
Couple great looking opportunities this week, otherwise equities look pretty quite with the broad sell offs we have seen. I am already at full risk after entering two trades last week so I will be sitting on my hands for now.
#1 Main Watch
VRTX HTF ACB L
Monthly - 0.50 Fib/Decel/50 ema
Weekly - Support/MACD/Double bottom
Daily - Support/MACD/Double bottom/Descending triangle/Decel/Wave 5 completion
LTF - Break out of descending triangle/MACD/Double bottom
Entry - Waiting for 1HR close above 50 ema
RR - 10 (Previous M/W highs)
Management - Long term
Additionally on Watch:
Main:
PENN Daily IBO L
Other:
6 stocks on this weeks development needed list
23 stocks on monthly watchlist (mostly in Tech & Health Care sectors)
Live Trades:
OOEG - Full Risk
AMC - 0.5% Profit locked in
MASS - Full Risk
VUZI - Full Risk
$Z - Full Risk
Couple great looking opportunities this week, otherwise equities look pretty quite with the broad sell offs we have seen. I am already at full risk after entering two trades last week so I will be sitting on my hands for now.
#1 Main Watch
VRTX HTF ACB LMonthly - 0.50 Fib/Decel/50 ema
Weekly - Support/MACD/Double bottom
Daily - Support/MACD/Double bottom/Descending triangle/Decel/Wave 5 completion
LTF - Break out of descending triangle/MACD/Double bottom
Entry - Waiting for 1HR close above 50 ema
RR - 10 (Previous M/W highs)
Management - Long term
Additionally on Watch:
Main:
PENN Daily IBO LOther:
6 stocks on this weeks development needed list
23 stocks on monthly watchlist (mostly in Tech & Health Care sectors)
Live Trades:
OOEG - Full Risk
AMC - 0.5% Profit locked inMASS - Full RiskVUZI - Full Risk$Z - Full Risk
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.